154 related articles for article (PubMed ID: 26712730)
1. Synthesis, Biological Evaluation and Molecular Docking Studies of 6-Aryl-2-Styrylquinazolin-4(3H)-Ones.
Agbo EN; Makhafola TJ; Choong YS; Mphahlele MJ; Ramasami P
Molecules; 2015 Dec; 21(1):E28. PubMed ID: 26712730
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives.
Fargualy AM; Habib NS; Ismail KA; Hassan AM; Sarg MT
Eur J Med Chem; 2013 Aug; 66():276-95. PubMed ID: 23811090
[TBL] [Abstract][Full Text] [Related]
3. 2-alkyl(aryl)-quinazolin-4(3H)-thiones, 2-R-(quinazolin-4(3H)-ylthio)carboxylic acids and amides: synthesis, molecular docking, antimicrobial and anticancer properties.
Antypenko L; Kovalenko S; Posylkina Y; Nikitin V; Fedyunina N; Ivchuk V
J Enzyme Inhib Med Chem; 2016; 31(2):253-65. PubMed ID: 25831026
[TBL] [Abstract][Full Text] [Related]
4. Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
Al-Omary FA; Hassan GS; El-Messery SM; Nagi MN; Habib el-SE; El-Subbagh HI
Eur J Med Chem; 2013 May; 63():33-45. PubMed ID: 23454532
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking, molecular modeling, vibrational and biological studies of some new heterocyclic α-aminophosphonates.
Awad MK; Abdel-Aal MF; Atlam FM; Hekal HA
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Jan; 206():78-88. PubMed ID: 30081271
[TBL] [Abstract][Full Text] [Related]
6. Novel substituted hydrazono indolo[2,1-b]quinazoline-6,12-dione analogues as cytostatic agents: Synthesis, crystal structure, biological evaluation and molecular docking studies.
Guda R; Narsimha S; Babu R; Muthadi S; Lingabathula H; Palabindela R; Yellu NR; Kumar G; Kasula M
Bioorg Med Chem Lett; 2016 Nov; 26(22):5517-5523. PubMed ID: 27769618
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation and molecular modeling study of new (1,2,4-triazole or 1,3,4-thiadiazole)-methylthio-derivatives of quinazolin-4(3H)-one as DHFR inhibitors.
El-Gazzar YI; Georgey HH; El-Messery SM; Ewida HA; Hassan GS; Raafat MM; Ewida MA; El-Subbagh HI
Bioorg Chem; 2017 Jun; 72():282-292. PubMed ID: 28499189
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Cytotoxicity and Molecular Docking Studies of the 9-Substituted 5-Styryltetrazolo[1,5-c]quinazoline Derivatives.
Mphahlele MJ; Gildenhuys S; Parbhoo N
Molecules; 2017 Oct; 22(11):. PubMed ID: 29072619
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antimicrobial activity and molecular modeling study of substituted 5-aryl-pyrimido[5,4-c]quinoline-2,4-diones.
Ismail MA; Al-Shihry S; Arafa RK; El-Ayaan U
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):530-8. PubMed ID: 22397395
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of some novel tetrahydroquinolines as anticancer and antimicrobial agents.
Faidallah HM; Saqer AA; Alamry KA; Khan KA; Asiri AM
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):367-78. PubMed ID: 23607308
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents.
Poudapally S; Battu S; Velatooru LR; Bethu MS; Janapala VR; Sharma S; Sen S; Pottabathini N; Iska VBR; Katangoor V
Bioorg Med Chem Lett; 2017 May; 27(9):1923-1928. PubMed ID: 28351589
[TBL] [Abstract][Full Text] [Related]
12. 2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes.
Piras S; Carta A; Briguglio I; Corona P; Paglietti G; Luciani R; Costi MP; Ferrari S
Eur J Med Chem; 2014 Mar; 75():169-83. PubMed ID: 24531230
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and In Vitro Cytotoxic Properties of Polycarbo-Substituted 4-(Arylamino)quinazolines.
Paumo HK; Makhafola TJ; Mphahlele MJ
Molecules; 2016 Oct; 21(10):. PubMed ID: 27754446
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Molecular Docking Study of Novel Heterocycles Incorporating 1,3,4-Thiadiazole Moiety as Potential Antimicrobial and Anticancer Agents.
El-Naggar M; Sallam HA; Shaban SS; Abdel-Wahab SS; E Amr AE; Azab ME; Nossier ES; Al-Omar MA
Molecules; 2019 Mar; 24(6):. PubMed ID: 30889918
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
Gangjee A; Lin X; Kisliuk RL; McGuire JJ
J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, and docking studies of some fused-quinazolines and quinazolines carrying biological active isatin moiety as cell-cycle inhibitors of breast cancer cell lines.
Radwan AA; Alanazi FK; Al-Dhfyan A
Drug Res (Stuttg); 2013 Mar; 63(3):129-36. PubMed ID: 23444171
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of antitumor acylated monoaminopyrroloquinazolines.
Chao B; Li BX; Xiao X
Bioorg Med Chem Lett; 2017 Jul; 27(14):3107-3110. PubMed ID: 28552339
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antitumor evaluation and docking study of novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor (EGFR) inhibitors.
Rao GW; Xu GJ; Wang J; Jiang XL; Li HB
ChemMedChem; 2013 Jun; 8(6):928-33. PubMed ID: 23640754
[TBL] [Abstract][Full Text] [Related]
19. Study of reactivity of cyanoacetohydrazonoethyl-N-ethyl-N-methyl benzenesulfonamide: preparation of novel anticancer and antimicrobial active heterocyclic benzenesulfonamide derivatives and their molecular docking against dihydrofolate reductase.
Debbabi KF; Al-Harbi SA; Al-Saidi HM; Aljuhani EH; Abd El-Gilil SM; Bashandy MS
J Enzyme Inhib Med Chem; 2016; 31(sup4):7-19. PubMed ID: 27557134
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents.
El-Naggar AM; Abou-El-Regal MM; El-Metwally SA; Sherbiny FF; Eissa IH
Mol Divers; 2017 Nov; 21(4):967-983. PubMed ID: 28815411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
